Skip to content

OviTex® PRS R20152-2020GRecalls & reported problems

Tela Bio, Inc. · The OviTex® PRS Reinforced Tissue Matrix Device is a sterile reinforced matrix device comprised of non-dermal sourced layers of extracellular matrix (ECM) (ovine (sheep) derived ECM), paired with a minimal suture footprint. The OviTex PRS Reinforced Tissue Matrix Device provides an alternative device solution to permanent synthetic, resorbable/bioabsorbable synthetic, and biologic meshes. The device is permeable to facilitate fluid management, provides controlled stretch, and will incorporate into recipient tissue with associated cellular and microvascular ingrowth. Reinforced tissue matrices remodel into host tissue while maintaining compatibility with the body. The OviTex PRS Reinforced Tissue Matrix Device is for use in plastic and reconstructive surgery. · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
0
Injuries reported
5
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00856072005012), received between Nov 11, 2020 and Jan 11, 2024 — classified as 5 injuries.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 1 reportsDec 2023: 1 reportsJan 2024: 1 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem3
  • Insufficient Device Problem Information1
  • Material Disintegration1

Patient problems

  • Fluid Discharge3
  • No Information1
  • Seroma1
  • Wound Dehiscence1

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • InjuryJan 11, 2024Material Disintegration; Material Disintegration

    A PATIENT UNDERWENT BILATERAL TWO-STAGE PRE-PECTORAL BREAST RECONSTRUCTION WITH OVITEX PRS AND TISSUE EXPANDERS. IT WAS REPORTED THAT A PATIENT EXPERIENCED UNILATERAL SEROMA RESULTING IN THE REMOVAL OF THE OVITEX PRS DEVICE AND THE TISSUE EXPANDER.

    Patient problems: Seroma

    MAUDE report 18492714 ↗
  • InjuryDec 22, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A PATIENT UNDERWENT UNILATERAL DELAYED PREPECTORAL BREAST RECONSTRUCTION WITH OVITEX PRS PGA AND A TISSUE EXPANDER ON (B)(6) 23. APPROXIMATELY 3 WEEKS AFTER THE ORIGINAL SURGERY FIBRINOUS EXUDATE WAS NOTED IN THE POCKET. THE DEVICE WAS ADHERENT AND INTACT ALONG THE PERIMETER AND POSTERIOR BUT NOT PRESENT ANTERIORLY. THE DEVICES WERE EXPLANTED ON (B)(6) 2023.

    Patient problems: Fluid Discharge

    MAUDE report 18388824 ↗
  • InjuryNov 2, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A PATIENT UNDERWENT BILATERAL PREPECTORAL BREAST RECONSTRUCTION WITH OVITEX PRS AND TISSUE EXPANDERS. IT WAS REPORTED THAT THE PATIENT PROGRESSED NORMALLY FOR A COUPLE OF WEEKS AND DRAINS WERE PULLED. DISCOLORATION APPEARED AROUND INCISIONS AND INCISIONS OPENED WITH FLUID DISCHARGE. ONE WOUND WAS REPORTED TO HAVE DEHISCED AND ALL DEVICES WERE REMOVED ON BOTH SIDES. THIS IS ONE OF TWO REPORTS FOR THE SAME PATIENT FOR THIS ISSUE.

    Patient problems: Fluid Discharge; Wound Dehiscence

    MAUDE report 18059303 ↗
  • InjuryOct 18, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A PATIENT UNDERWENT TWO-STAGE BILATERAL BREAST RECONSTRUCTION WITH TISSUE EXPANDERS AND OVITEX PRS PGA ON APPROXIMATELY (B)(6) 2023. IT WAS REPORTED THAT ON (B)(6) 2023 THE OVITEX PRS DEVICES HAD POSSIBLY BROKEN DOWN AND EXTRUDED THROUGH THE PATIENT'S INCISIONS. THE DEVICES WERE REMOVED TO THE EXTENT POSSIBLE, TISSUE EXPANDERS LEFT IN PLACE, AND RECONSTRUCTION COURSE CONTINUED.

    Patient problems: Fluid Discharge

    MAUDE report 17961040 ↗
  • InjuryNov 11, 2020Insufficient Device Problem Information; Insufficient Device Problem Information

    A PATIENT UNDERWENT A UNILATERAL (LEFT) MASTECTOMY AND PREFECTORAL TWO-STAGE BREAST RECONSTRUCTION WITH A TEXTURED TISSUE EXPANDER AND OVITEX PRS. THE EXPANDER AND OVITEX PRS WERE IMPLANTED ON (B)(6) 2020. THE PATIENT RETURNED ON (B)(6) 2020 FOR AN UNKNOWN FOLLOW-UP SURGICAL PROCEDURE. UPON OPENING THE INCISION, THE SURGEON NOTED THAT PORTIONS OF THE OVINE TISSUE WERE NO LONGER PRESENT AT THE SURGICAL SITE. THE SURGEON REMOVED THE OVITEX PRS AND LEFT THE EXPANDER INSERTED.

    Patient problems: No Information

    MAUDE report 10822213 ↗

Other Mesh, Surgical devices

All Mesh, Surgical devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page